INTRODUCTION
Francisella tularensis, the aetiological agent of tularaemia, is a highly infectious, facultative intracellular bacterium (Dorofe'ev, 1947; McCoy & Chapin, 1912; Sjöstedt, 2006) . This highly virulent member of the class cproteobacteria of Gram-negative bacteria is capable of infecting a wide range of mammalian species, including man (Mörner, 1992; Sjöstedt, 2006) . There are currently three accepted subspecies of F. tularensis with differing geographical distributions: the highly virulent subspecies tularensis (also known as type A) is found almost exclusively in North America (Olsufiev et al., 1959; Olsufjev & Meshcheryakova, 1982) ; the less virulent subspecies holarctica (also known as type B) is found in both North America and Eurasia (Olsufiev et al., 1959; Olsufjev & Meshcheryakova, 1982) ; and subspecies mediasiatica is of similar virulence to subspecies holarctica and is only found in the central Asian republics of the former Soviet Union (Olsufiev et al., 1959; Olsufjev & Meshcheryakova, 1982) . A fourth subspecies, novicida, has been proposed, but at the time of writing Francisella novicida remains a separate species (Euzéby, 1997; Forsman et al., 1994; Hollis et al., 1989) .
There are several forms of human tularaemia, dependent upon the route of infection (Dennis et al., 2001; Hubálek et al., 2004) . Ulceroglandular tularaemia, acquired by dermal routes of infection, is the most common natural presentation, but pneumonic tularaemia following inhalation is the most acute form, with the highest associated mortality (Gill & Cunha, 1997) . Upon entry into the host, F. tularensis is able to evade the immune system and replicate in the cytosol of infected macrophages (Checroun et al., 2006; Clemens et al., 2004) . From there, F. tularensis spreads from the site of infection via the regional lymph nodes and disseminates systemically to organs, including the liver, spleen and lungs (Checroun et al., 2006; Hubálek et al., 2004) .
The enzyme c-glutamyl transpeptidase (GGT) catalyses the hydrolysis of c-glutamyl compounds, mediating the transfer of c-glutamyl moieties to amino acids and peptides (Tate & Meister, 1981) . It is present in both eukaryotes and prokaryotes; the bacterial enzyme has been shown to be associated with either the inner membrane or the periplasm, whereas eukaryotic GGT is anchored at the N terminus to the plasma membrane (Ikeda et al., 1995; Tate & Meister, 1981; Xu & Strauch, 1996) . GGT is reported to have a variety of functions, with one of the major roles being participation in the c-glutamyl cycle, where it catalyses the degradation of the antioxidant molecule reduced glutathione (GSH) to L-c-glutamyl and L-cysteinylglycine in the first step of a reaction resulting in the acquisition of cysteine (Gregus et al., 1987; Tate & Meister, 1981) . Interestingly, in light of the cysteine auxotrophy displayed by F. tularensis, GGT is reported to play a role in the supply of cysteine from environmental peptides to Neisseria meningitidis during periods of cysteine shortage (Takahashi et al., 2004) . In a previous study to elucidate virulence mechanisms employed by Francisella, transcriptional analysis was undertaken on F. novicida cultured in vitro under iron-starvation conditions (LeButt, 2008; Milne et al., 2007) . A number of genes were observed to be upregulated under these conditions, one of which was homologous to ggt enzymes, indicating an important role for GGT in vivo.
A recent investigation using the empirically derived, attenuated strain F. tularensis subsp. holarctica LVS demonstrated that GGT plays a role in cysteine synthesis, and that deletion of ggt attenuates the residual virulence that is displayed by the vaccine strain in mice (Alkhuder et al., 2009 ). An F. tularensis SCHU S4 ggt mutant, identified by transposon mutation, is attenuated in hepatic carcinoma cell line HepG2 cells (Qin & Mann, 2006) , and a defined SCHU S4 ggt mutant is attenuated in a murine model (Kadzhaev et al., 2009) . However, these mutants were not characterized any further, for example, gene function was not restored through complementation.
F. tularensis LVS was originally derived through in vitro subculture (Tigertt, 1962) , and as such contains multiple genetic defects (Conlan & Oyston, 2007) . LVS can induce protective immune responses in man, but as the genetic basis of attenuation remains to be elucidated, LVS is yet to receive full licensure (Conlan & Oyston, 2007) . There are an increasing number of targeted mutants created in F. tularensis SCHU S4 that are attenuated in the murine model of infection (Kadzhaev et al., 2009 ), but although some have been shown to offer protection, such as strains lacking clpB, fupA or capB (Shen et al., 2010) , many when used to vaccinate mice rarely offer sufficient protection against homologous challenge (Kadzhaev et al., 2009) . We wished to evaluate a mutant of F. tularensis SCHU S4 Dggt as a live attenuated vaccine strain. The challenge of a live vaccine is balancing attenuation, required for safety, with immunogenicity. If a strain is overly attenuated the correct immune response will not be induced, and mere persistence has been shown not to be sufficient for immunogenicity (Twine et al., 2005) .
In this study an isogenic in-frame deletion mutant for ggt was generated in the F. tularensis strain SCHU S4. In order to confirm the function of ggt in a fully virulent isolate, as reported for the attenuated LVS strain (Alkhuder et al., 2009) , the effect of this mutation on GGT activity and the ability of the subspecies tularensis SCHU S4 ggt mutant to obtain and use cysteine from GSH was investigated. To confirm that this mutation was attenuating in a highly virulent strain, the ability of bacteria to infect macrophages and mice was also investigated. The protective efficacy of this mutant against a fully virulent SCHU S4 challenge was also evaluated for the first time.
METHODS
Bacterial strains and culture conditions. The bacterial strains used in this study are listed in Table 1 . Strains of F. tularensis were grown routinely on blood cysteine glucose agar supplemented with 4 % cysteine, 4 % histidine, 5 % glucose and 10 % fresh filtered horse blood (BCGA), solidified Chamberlain's defined medium (CDM) (Chamberlain, 1965) or Thayer-Martin agar (Atlas, 2004) . Where required, media were supplemented with 100 mg polymyxin ml 21 , 12.5 mg kanamycin ml 21 and 13.5 mg tetracycline ml 21 . Strains of Escherichia coli were grown in Luria-Bertani (LB) medium (Atlas, 2004) or on LB agar at 37 uC, supplemented as required with 25 mg kanamycin ml
21
. All work undertaken with Francisella strains was F. tularensis SCHU S4 Dggt is attenuated and protective performed under appropriate laboratory containment conditions in accordance with relevant legislative requirements. The use of tetracycine as a marker was approved for this work and was reviewed locally by a genetic manipulation safety committee and also approved nationally by our health and safety authorities.
Plasmids and manipulation of DNA. Generally, the manipulation of DNA was carried out as outlined elsewhere (Owens & Hartman, 1986) . Genomic DNA was isolated using the Gentra Puregene DNA Isolation kit (Qiagen). Plasmid DNA was isolated using Qiagen Plasmid Mini and Maxi kits. Plasmids used in this study are shown in Table 1 . Southern blotting was performed under high-stringency conditions as detailed by Sambrook & Russell (2001) . Standard PCR was performed with 25 cycles of 94 uC for 30 s, 50 uC for 30 s, and 72 uC for 30 s.
Generation of an F. tularensis Dggt mutant. Primers were designed from the genome sequence of F. tularensis SCHU S4, such that a 1787 bp deletion was generated in the ggt (FTT1181c) ORF. Primers were used to amplify DNA regions flanking the deletion (left flank forward, ggtF1: 59-ACGCGTTAGGTTACCTTGGGCTTGAG-39; reverse, ggtR1: 59-AGATCTGGTTATTAAACACTTTAATAG-39; right flank forward, ggtF2: 59-AGATCTACGACGCATTAAAGAAAC-39, reverse, ggtR2: 59-ACGCGTTGTGGGATTAAGTGGGAAACC-39). These amplicons were ligated with pGEM-T Easy (Promega) according to the manufacturer's protocol to generate pGEMggt1 and pGEMggt2 containing left and right flanks, respectively. The two plasmids were digested with BglII to linearize them, and they were then ligated. The ligated plasmids were used as template in a PCR to join the two flanks, using primers ggtF1 and ggtR2. The product was ligated with pGEM-T Easy as above and used to transform E. coli JM109. Plasmids were isolated and the correct sequence was confirmed by PCR. One correct clone was digested with MluI, and the insert was isolated and ligated with similarly digested pSMP75 to produce pSM75Dggt. Plasmid pSM75Dggt was introduced into F. tularensis SCHU S4 by conjugation using the method of Golovliov et al. (2003) .
Briefly, E. coli S17-lpir pSM75Dggt was grown overnight in LBkanamycin, a 1 ml aliquot was removed, and the bacteria were sedimented by centrifugation and resuspended in 50 ml fresh LB broth. The Francisella were grown on BCGA overnight at 37 uC in a confluent lawn. Bacteria were removed using a sterile loop and resuspended in the E. coli suspension, and the mixture spotted onto BCGA. After incubation overnight at 25 uC, the bacteria were removed with a sterile loop and suspended in 500 ml PBS before being inoculated onto Thayer-Martin agar supplemented with 100 mg polymyxin ml 21 (to inhibit growth of the E. coli) and 12.5 mg kanamycin ml
. Colonies were subcultured onto Thayer-Martin agar supplemented with 5 % sucrose. Isolated colonies that grew in the presence of sucrose were analysed by PCR for the deletion of the ggt ORF and loss of the vector. This was subsequently confirmed by Southern blotting. The strain was designated F. tularensis SCHU S4 Dggt.
Complementation of F. tularensis SCHU S4 Dggt. The F. tularensis SCHU S4 Dggt strain was complemented using the native promoter by cloning the region 1052 bp upstream to 942 bp downstream of the ggt gene using the primers 59-GGTACCAATTA-TTGCTAAGCTTATTTATACACCACAG-39 forward and 59-GGTA-CCTAGCTTAGATTAATTATTCAAATTACTAAG-39 reverse. The amplicon was ligated with pSMP6oriT that had been digested using KpnI and contained a tetracycline-resistance cassette. The plasmid was introduced into F. tularensis SCHU S4 Dggt by conjugation, again using the method of Golovliov et al. (2003) . The strain was designated F. tularensis SCHU S4 Dggt_C.
Assay for GGT activity. The GGT activity of both mutant and wildtype F. tularensis was determined by measuring optically the release of p-nitroaniline from L-c-glutamyl-p-nitroanilide as described elsewhere, with minor modifications (Huseby & Strömme, 1974) . Briefly, reaction buffer, consisting of 1 mM L-c-glutamyl-p-nitroanilide, 20 mM Gly-Gly, and 60 mM Tris-HCl (pH 8.0) was prepared, and 180 ml was applied to each well of a 96-well microtitre plate. Bacteria were suspended in PBS to an OD 590 of 0.6, and 20 ml was also applied to each well. Assays were performed at 37 uC for 23 h, at which point the A 405 of each well was measured.
Growth in the absence of exogenous cysteine. Overnight cultures of bacteria on BCGA were suspended in PBS and used to inoculate media to a starting OD 590 of 0.14. Cultures were incubated at 37 uC with shaking at 150 r.p.m. for 19 h, following which the OD 590 was measured as an indication of bacterial growth. Growth was measured in the following media: CDM, CDM prepared without cysteine (CDM 2cys), and CDM 2cys supplemented with 0.6 mM GSH.
Survival in J774.A1 macrophages. Bacterial survival in J774.A1 murine macrophages was studied with the method described by Golovliov et al. (1997) , using an m.o.i. of 10. Briefly, J774A.1 cells were cultured in 24-well tissue culture plates at 37 uC with 5 % (v/v) CO 2 until confluent monolayers of approximately 1610 6 cells per well were established. The culture medium was removed from the cells and replaced with 0.1 ml bacterial suspension at 1610 8 c.f.u. ml 21 . Infected monolayers were incubated as before for 30 min to allow bacterial invasion of the cells. The inoculum was aspirated and the monolayer washed with PBS three times. Cells were then overlaid with culture medium containing 10 mg gentamicin ml 21 and incubated as before for 30 min to kill any remaining extracellular bacteria. The medium was aspirated and the monolayer again washed with PBS three times. Finally, the cells were overlaid with maintenance medium containing 2 mg gentamicin ml 21 and incubated as before. This was denoted time point 0 h post-infection. At time points 1, 24 and 48 h, bacteria were recovered from duplicate monolayers by aspiration of the media, washing in PBS, and lysis using sterile water. Cell lysates were decimally diluted in PBS, and the number of viable, internalized bacteria was determined by counting the resultant colonies on BCGA. This experiment was repeated in triplicate.
Virulence and protection of BALB/c mice. Groups of six 6-8 week-old, female BALB/c mice (Charles RiverUK) were dosed by the subcutaneous (sc) route with serial dilutions of bacteria in PBS. The concentration of bacteria in the inoculum was determined by retrospective viable count. Mice surviving the initial challenge were subsequently challenged (sc) 49 days later with wild-type bacteria to determine whether a protective immune response had been induced. Humane end points were strictly observed, and animals deemed incapable of survival were humanely killed by cervical dislocation. The median lethal dose (MLD) to induce morbidity or death is approximately 1 c.f.u. for F. tularensis SCHU S4 given by the sc route (Green et al., 2005) .
Statistical analyses. Statistical differences in recovered c.f.u. from infected J774.A1 and in GGT activity were determined using a repeated measures analysis of variance (ANOVA) with Bonferroni's multiple comparisons test and Student's t test, respectively.
RESULTS
To determine the function of GGT in F. tularensis, a mutant was constructed in strain SCHU S4. PCR and Southern blot analysis confirmed the double crossover and successful allelic replacement of the gene (data not shown). The GGT activity of F. tularensis SCHU S4 and F. tularensis SCHU S4 Dggt was determined by assaying the release of pnitroaniline from L-c-glutamyl-p-nitroanilide at 37 u C for 23 h. The mean GGT activity was observed to be approximately 11-fold higher in F. tularensis SCHU S4 than in F. tularensis SCHU S4 Dggt (P,0.001) (Fig. 1) . Complementation of the ggt mutation with a plasmid containing the gene resulted in full restoration to the wildtype phenotype.
To test whether GGT in F. tularensis SCHU S4 plays a role in the acquisition of cysteine from GSH, the growth of F. tularensis SCHU S4 and F. tularensis SCHU S4 Dggt was compared in vitro in cysteine-depleted media that was supplemented with GSH. The results of triplicate assays are shown in Fig. 2 . The growth of both the wild-type and mutant was reduced by approximately fivefold in CDM 2cys compared with CDM. The addition of 0.6 mM GSH to the CDM 2cys media restored the growth of F. tularensis SCHU S4 to a similar level to that observed in CDM, whereas the growth of F. tularensis SCHU S4 Dggt was only restored following complementation with a ggtexpressing plasmid.
The potential role of GGT in F. tularensis virulence was tested by comparing the mutant and wild-type strains in a well-established murine macrophage model of infection. At 24 h post-infection, with an m.o.i. of 10, the number of viable F. tularensis SCHU S4 recovered from J774A.1 murine macrophage-like cells was approximately two times higher than the number of viable F. tularensis SCHU S4 Dggt recovered (P,0.001), a trend which was continued at 48 h post-infection (Fig. 3) . Complementation of the ggt mutation resulted in partial restoration of wild-type virulence, such that the c.f.u. recovered were intermediate between those of SCHU S4 and Dggt and significantly different from both (P,0.001). The potential attenuation of the F. tularensis SCHU S4 mutant strain was also investigated using a murine model of infection. BALB/c mice received doses of F. tularensis SCHU S4 Dggt ranging from 8.75 c.f.u. to 8.75610 6 c.f.u. in one-log increments via the sc route. Control mice that received 1.3610 3 c.f.u. F. tularensis SCHU S4 had all reached the humane end point by 4 days post-infection. Mice that received F. tularensis SCHU S4 Dggt survived in a dose-dependent manner ( Table 2 ). The MLD of F. tularensis SCHU S4 Dggt was calculated as approximately 2610 6 c.f.u., compared with a wild-type F. tularensis MLD of approximately 1 c.f.u.
The protective efficacy of F. tularensis SCHU S4 Dggt against a wild-type challenge was also investigated using the murine model of infection. Mice that survived vaccination with F. tularensis SCHU S4 Dggt were subsequently challenged with 100 MLD F. tularensis SCHU S4. Mice vaccinated with 8.75610 2 c.f.u. F. tularensis SCHU S4 Dggt or less did not show total protection, whereas mice that received 8.75610 3 c.f.u. F. tularensis SCHU S4 Dggt or more were fully protected (Fig. 4) .
DISCUSSION
There is a pressing need for a licensable F. tularensis vaccine candidate. Much effort has been expended attempting to license the LVS strain (Conlan & Oyston, 2007) , but as yet this has not been achieved. Similarly, attempts to identify protective subunit formulations have been unsuccessful to date (Oyston & Griffiths, 2009 ). As such, a novel, defined, live attenuated vaccine candidate may offer a safe and effective alternative. There has thus been a drive to identify genes which, when inactivated, produce safe immunogenic mutants (Kadzhaev et al., 2009; Michell et al., 2010; Pechous et al., 2008; Qin et al., 2008; Shen et al., 2010; Thomas et al., 2007; Twine et al., 2005) . Preliminary results indicate that ggt may be a suitable target for inactivation, as it is attenuating in LVS and SCHU S4 (Alkhuder et al., 2009; Kadzhaev et al., 2009; Qin & Mann, 2006) . However, the function of the encoded protein in the highly virulent subspecies has not been confirmed, nor has the induced immune response been characterized for protective efficacy. Extrapolating observations between Francisella species and subspecies is not always appropriate. For example, F. tularensis subsp. tularensis O antigen has been identified as important for intracellular survival, but in F. novicida this gene does not confer such an advantage, being instead important for viability before entering a host cell (Thomas et al., 2007) . In addition, the deletion of pilin homologues in F. tularensis LVS produces significant attenuation, in contrast to SCHU S4, in which attenuation is not observed, suggesting a different role in the fully virulent strain (Ark & Mann, 2011) . Similar discrepancies between mutants created in LVS and SCHU S4 have been observed in an RND-like efflux pump (Qin & Mann, 2006) and catalase (katG) (Bina et al., 2008) , emphasizing the need fully to characterize phenotypes in virulent strains. We therefore created an in-frame deletion mutant to undertake these studies and confirm the role of GGT in SCHU S4.
The results of the p-nitroanilide assay for GGT activity carried out using wild-type, mutant and complemented strains demonstrated that, as in F. tularensis LVS, the ggt of F. tularensis SCHU S4 does encode GGT (Alkhuder et al., 2009) . Growth of the mutant and wild-type strains in vitro was comparable, suggesting that GGT is not essential for in subsequently challenged with 100 MLD of F. tularensis SCHU S4.
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vitro growth of F. tularensis (Fig. 2) . This is in agreement with previously published Dggt strains constructed in Campylobacter jejuni and N. meningitidis (Barnes et al., 2007; Takahashi et al., 2004) . However, the expression of active GGT by the wild-type strain cultured in vitro seems to indicate that, although not essential, GGT may still contribute to the ability of F. tularensis to overcome growth-limiting factors.
The restoration of growth of F. tularensis strains encoding intact ggt upon addition of GSH (in the absence of free cysteine) demonstrates that strain SCHU S4 does utilize GGT to acquire cysteine from GSH. This supports the findings of Alkhuder et al. (2009) in that GSH was used to restore the growth of F. tularensis LVS, but not F. tularensis LVS Dggt, cultured in the absence of cysteine. However, restoration of the growth of the attenuated LVS strain was only partial upon addition of GSH, compared with the full restoration of F. tularensis SCHU S4 growth. F. tularensis LVS was originally derived through in vitro subculture (Thomas et al., 2007) , and despite the completion of the genome sequence (P. Chain and others, unpublished results), the physiological nature of F. tularensis LVS attenuation remains to be elucidated. It is likely that F. tularensis LVS contains a number of disrupted functions, and this, taken together with a lack of full restoration of growth by GSH, could indicate that in the vaccine strain GGT serves some additional purpose, the absence of which could not be overcome by the addition of GSH.
It is often difficult through complementation in trans to completely restore observed phenotypes in targeted deletion mutants (Ark & Mann, 2011; Brotcke et al., 2006; Lai et al., 2004) . Partial restoration (Fig. 3 ) of the GGT mutant in macrophages may have been a consequence of expression above wild-type levels due to copy number. Additional breakdown of the potentially beneficial GSH by Dggt_C may account for the absence of full restoration, as GSH is a welldocumented antioxidant molecule, and has been demonstrated to provide protection to all cells against reactive oxygen and nitrogen species through electron donation (Masip et al., 2006; Wills, 1966) . It has also been shown to protect bacteria against acid stress, chlorine compounds and osmotic stress (Masip et al., 2006; Owens & Hartman, 1986; Riccillo et al., 2000) . Therefore, while these data do provide evidence of a role for GGT in F. tularensis cysteine acquisition in vitro, they may also indicate that the addition of GSH provides some other, GGT-independent, benefit to F. tularensis SCHU S4 cultured under these conditions.
In addition to the attenuation for virulence demonstrated by F. tularensis SCHU S4 Dggt, and by the LVS mutant in the same gene (Alkhuder et al., 2009; Kadzhaev et al., 2009) , there are several prior examples of a role for GGT in virulence. In the intracellular fungal pathogen Histoplasma capsulatum, which resides in macrophages, GGT has been shown to play a role in both the c-glutamyl cycle and also in iron acquisition: the thiol group of the dipeptide released upon GGT-mediated degradation of GSH is able to efficiently reduce ferric iron to the more usable ferrous form (Zarnowski et al., 2008) . In C. jejuni, GGT has been shown to be required for persistent colonization of the avian gut (Barnes et al., 2007) . GGT has also been shown to play a role in the colonization of murine gastric mucosa by Helicobacter pylori, potentially enabling survival through participation in the de novo synthesis of essential amino acids (Chevalier et al., 1999; Gong & Ho, 2004; McGovern et al., 2001) . In addition, an F. tularensis SCHU S4 ggt transposon mutant is defective for intracellular replication in the hepatic carcinoma cell line HepG2 (Qin & Mann, 2006) .
The level of attenuation for virulence (in BALB/c mice) of F. tularensis SCHU S4 Dggt described here is in agreement with an F. tularensis SCHU S4 ggt mutant identified elsewhere (Kadzhaev et al., 2009) . Moreover, this one millionfold level of attenuation of F. tularensis SCHU S4 Dggt in mice is reflective of, but far exceeds, the thousandfold level of attenuation reported for F. tularensis LVS Dggt in a murine model of infection (Alkhuder et al., 2009) . The reduced level of attenuation observed in F. tularensis LVS Dggt (compared with F. tularensis SCHU S4 Dggt), both in vivo and in vitro, may be due to the high level of attenuation already displayed by F. tularensis LVS masking the effect of the ggt mutation. This, together with its undefined nature, makes F. tularensis LVS a suboptimal strain for the evaluation and characterization of mutants. Conversely, fully virulent strains, such as F. tularensis SCHU S4, display the full effects of mutations in a more clinically relevant framework.
Attenuated mutant strains need to balance attenuation, for safety, with the ability to induce a protective immune response. Additionally, it is hard to predict whether an attenuated strain will induce protective immune responses against challenge with a fully virulent strain. For example, DpurA mutants are overly attenuated, as they fail to induce a protective immune response (Quarry et al., 2007; Tempel et al., 2006) , whereas mutants defective in genes further down the purine biosynthetic pathway provide protective immunity (Pechous et al., 2009) . In this study, we have demonstrated that the ggt mutant is able to induce protective responses in mice, and that it may be a candidate for inactivation in a live attenuated vaccine, although for safety reasons more than one attenuating mutation will need to be included in a defined vaccine strain, and the effects of combining mutations is hard to predict.
In conclusion, the data presented here demonstrate that GGT is required for virulence in F. tularensis SCHU S4. Deletion of ggt is attenuating, and the mutant elicits a protective immune response against a fully virulent wildtype challenge. We have confirmed a function of GGT in fully virulent F. tularensis subsp. tularensis SCHU S4, and that starvation for cysteine is likely to be the cause of attenuation. The undefined nature of F. tularensis LVS, together with the fact that it can cause a tularaemia-like disease in some individuals, means that there is a requirement for an improved vaccine against F. tularensis. The attenuated and protective nature of F. tularensis SCHU
